Gujarat Themis Biosyn Limited (GTBL), a niche pharmaceutical manufacturer specializing in fermentation-based intermediates, is entering a decisive phase of strategic evolution. BP Equities Pvt.

Axis Securities has reiterated a BUY recommendation on Ambuja Cements Ltd with a revised target price of Rs 630, citing transformational consolidation moves and a clear path to scale-led efficiency

Torrent Pharmaceuticals Ltd.

Research House Prabhudas Lilladher has reiterated its ‘BUY’ rating on Ambuja Cements (ACEM), setting a revised target price of Rs692.

Motilal Oswal Financial Services has reiterated its BUY recommendation on Ambuja Cements, setting a target price of Rs 700—a 21% upside from the current market price of Rs 580.

Prabhudas Lilladher has issued an “ACCUMULATE” recommendation on Torrent Pharmaceuticals (TRP), with a target price of Rs3,850 per share.